Recent data have shown that maternal circulating levels of EG-VEGF are increased in patients undergoing molar pregnancies, a severe form of the gestational trophoblastic disease (GTD) [72]. This evidence concerns the gene VEGFA and gestational trophoblastic neoplasm.